These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32083584)

  • 21. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apelin-36 mitigates MPTP/MPP
    Zhu J; Dou S; Wang C; Jiang Y; Wang C; Cheng B
    Brain Res; 2019 Oct; 1721():146334. PubMed ID: 31306618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity.
    Srivastav S; Neupane S; Bhurtel S; Katila N; Maharjan S; Choi H; Hong JT; Choi DY
    J Nutr Biochem; 2019 Jul; 69():73-86. PubMed ID: 31063918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic activation of autophagy by combined treatment with rapamycin and trehalose in a mouse MPTP-induced model of Parkinson's disease.
    Pupyshev AB; Tikhonova MA; Akopyan AA; Tenditnik MV; Dubrovina NI; Korolenko TA
    Pharmacol Biochem Behav; 2019 Feb; 177():1-11. PubMed ID: 30582934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NADPH ameliorates MPTP-induced dopaminergic neurodegeneration through inhibiting p38MAPK activation.
    Zhou JS; Zhu Z; Wu F; Zhou Y; Sheng R; Wu JC; Qin ZH
    Acta Pharmacol Sin; 2019 Feb; 40(2):180-191. PubMed ID: 29769744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
    Lofrumento DD; Nicolardi G; Cianciulli A; De Nuccio F; La Pesa V; Carofiglio V; Dragone T; Calvello R; Panaro MA
    Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective effects of α-ketoglutarate and ethyl pyruvate against motor dysfunction and oxidative changes caused by repeated 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine exposure in mice.
    Satpute R; Lomash V; Kaushal M; Bhattacharya R
    Hum Exp Toxicol; 2013 Jul; 32(7):747-58. PubMed ID: 23821591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.
    Guo B; Hu S; Zheng C; Wang H; Luo F; Li H; Cui W; Yang X; Cui G; Mak S; Choi TC; Ma ED; Wang Y; Lee SMY; Zhang Z; Han Y
    Neuropharmacology; 2017 Nov; 126():12-24. PubMed ID: 28807675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fingolimod (FTY720) is not protective in the subacute MPTP mouse model of Parkinson's disease and does not lead to a sustainable increase of brain-derived neurotrophic factor.
    Komnig D; Dagli TC; Habib P; Zeyen T; Schulz JB; Falkenburger BH
    J Neurochem; 2018 Dec; 147(5):678-691. PubMed ID: 30152864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-inflammatory and anti-apoptotic effects of (RS)-glucoraphanin bioactivated with myrosinase in murine sub-acute and acute MPTP-induced Parkinson's disease.
    Galuppo M; Iori R; De Nicola GR; Bramanti P; Mazzon E
    Bioorg Med Chem; 2013 Sep; 21(17):5532-47. PubMed ID: 23810671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mangiferin attenuates MPTP induced dopaminergic neurodegeneration and improves motor impairment, redox balance and Bcl-2/Bax expression in experimental Parkinson's disease mice.
    Kavitha M; Nataraj J; Essa MM; Memon MA; Manivasagam T
    Chem Biol Interact; 2013 Nov; 206(2):239-47. PubMed ID: 24095822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nervonic acid alleviates MPTP-induced Parkinson's disease via MEK/ERK pathway.
    Zhang X; Wu D; Yin Z
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):100-106. PubMed ID: 38678620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
    Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
    J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats.
    Bisht R; Kaur B; Gupta H; Prakash A
    Neurotoxicology; 2014 Sep; 44():71-9. PubMed ID: 25053526
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.
    Bao XQ; Wu LY; Wang XL; Sun H; Zhang D
    Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):549-56. PubMed ID: 25678053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dangguijakyak-san protects dopamine neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity under postmenopausal conditions.
    Lee JM; Hwang DS; Kim HG; Lee CH; Oh MS
    J Ethnopharmacol; 2012 Feb; 139(3):883-8. PubMed ID: 22178176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection by freshwater clam extract against the neurotoxin MPTP in C57BL/6 mice.
    Hsieh CC; Lin MS; Hua KF; Chen WJ; Lin CC
    Neurosci Lett; 2017 Mar; 642():51-58. PubMed ID: 28126590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.